Page last updated: 2024-11-06

3,3',5-triiodothyroacetic acid and Coronary Disease

3,3',5-triiodothyroacetic acid has been researched along with Coronary Disease in 3 studies

tiratricol : A monocarboxylic acid that is (4-hydroxy-3,5-diiodophenyl)acetic acid in which the phenolic hydroxy group has been replaced by a 4-hydroxy-3-iodophenoxy group. It is a thyroid hormone analogue that has been used in the treatment of thyroid hormone resistance syndrome.

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BOYD, GS2
OLIVER, MF2
MECIANI, L2
BRINA, A2

Other Studies

3 other studies available for 3,3',5-triiodothyroacetic acid and Coronary Disease

ArticleYear
The influence of triiodothyroacetic acid on the circulating lipids and lipoproteins in euthyroid men with coronary disease.
    Lancet (London, England), 1957, Jan-19, Volume: 272, Issue:6960

    Topics: Coronary Disease; Heart; Hematologic Diseases; Humans; Lipids; Lipoproteins; Male; Triiodothyronine

1957
The influence of triiodothyroacetic acid on the circulating lipids and lipoproteins in euthyroid men with coronary disease.
    Lancet (London, England), 1957, Jan-19, Volume: 272, Issue:6960

    Topics: Coronary Disease; Heart; Hematologic Diseases; Humans; Lipids; Lipoproteins; Male; Triiodothyronine

1957
The influence of triiodothyroacetic acid on the circulating lipids and lipoproteins in euthyroid men with coronary disease.
    Lancet (London, England), 1957, Jan-19, Volume: 272, Issue:6960

    Topics: Coronary Disease; Heart; Hematologic Diseases; Humans; Lipids; Lipoproteins; Male; Triiodothyronine

1957
The influence of triiodothyroacetic acid on the circulating lipids and lipoproteins in euthyroid men with coronary disease.
    Lancet (London, England), 1957, Jan-19, Volume: 272, Issue:6960

    Topics: Coronary Disease; Heart; Hematologic Diseases; Humans; Lipids; Lipoproteins; Male; Triiodothyronine

1957
[POSSIBILITIES AND LIMITS OF AMBULATORY TREATMENT OF THE DYSLIPIDOSES IN CORONARY DISEASE WITH TRIAC (TRIIODOTHYROACETIC ACID). USE OF TRIAC ALONE].
    Minerva medica, 1964, Sep-29, Volume: 55

    Topics: Coronary Disease; Electrocardiography; Humans; Hypercholesterolemia; Lipoproteins; Thyroid Hormones;

1964
[POSSIBILITIES AND LIMITATIONS OF THE AMBULATORY TREATMENT OF DISLIPIDEMIA IN CORONARY DISEASE PATIENTS WITH TRIAC (TRIIODOTHYROACETIC ACID). II.USE OF TRIAC ASSOCIATED WITH VITAMIN A AND DIVANILLIDENE-CYCLOHEXANONE (D.V.C.E.)].
    Minerva medica, 1964, Oct-10, Volume: 55

    Topics: Aged; Cholesterol; Coronary Disease; Cyclohexanones; Drug Therapy; Humans; Hyperlipidemias; Lipids;

1964